Similar Items: Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort
- Acute lymphoblastic leukemia in adolescents and young adults – from genomics to the clinics
- Challenges faced in the treatment of acute lymphoblastic leukemia in adolescents and young adults
- Thyroid profile in acute lymphoblastic leukemia: prognostic role of thyrotropin-releasing hormone
- Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia
- Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia
- Descriptive Epidemiology and Prognosis of Pediatric Acute Leukemia in the Afro‐Descendant Population of the French West Indies and French Guiana